Bunge Loders Croklaan introduces Betapol Plus
At Fi Europe, Bunge Loders Croklaan (BLC), the edible oil business of Bunge Limited, unveiled Betapol Plus, its next generation of premium quality Oleic-Palmitic-Oleic (OPO or SN-2 palmitate) lipids for infant formula. Betapol Plus is the most advanced OPO product of its kind and delivers on BLC’s aim to provide the best solutions for modern-day infant nutrition.
OPO is naturally present in mother’s milk, with 60-75% palmitic acid levels in the middle, or SN-2, position, and oleic acid in the outer SN-1 and SN-3 positions. This unique OPO lipid structure allows babies to absorb more nutrients.
Until now, no ingredient supplier could provide an OPO or SN-2 palmitate level that surpassed 40-45% and most commercial infant formulas have mainly POP (Palmitic-Oleic-Palmitic) fats. Recently awarded the Fi Europe 2019 Innovation Award for Functional Innovation, the new Betapol Plus blend for infant formula offers a 60% OPO or SN-2 palmitate level, which is the highest level available on the market, up to 50% higher than current products. This new solution is closer to the levels in mother’s milk fat than any offering available on the market.
“This new Betapol product is definitely a milestone in our lipid solutions innovation, but not the end,” said Emiliano Rial Verde vice president nutrition at BLC. “Taking advantage of our 30-year experience in specialty lipids for infant nutrition, we are continuously studying the composition and structure of human breast milk to provide customers and consumers with innovative products that are closer and closer to nature.”
“There is a strong need in the infant milk formula industry to get as close as possible to the composition and benefits of mother’s milk, ensuring parents have the best alternative available when breastfeeding is not possible.”
“With Betapol Plus, we are providing an option that is closest to nature. It adds significant value to infant formula brands where premium choices are in high demand and to the growing specialty infant formula market addressing diverse dietary needs,” Emiliano Rial Verde added.
Developed by BLC, the science behind Betapol Plus is backed by robust clinical studies, scientific research programs and established relationships with key infant nutrition authorities in Europe.
“We all agree that breastfeeding is important for infant nutrition and bonding,” said Wiola Mi, global human nutrition science lead of the new generation Betapol. “But when breastfeeding is not an option, choosing the best infant formula, with the best evidence-backed ingredients, is key for babies’ healthy growth and development.”